Insiders · Profile

WITTE OWEN N.

Director at Allogene Therapeutics. Filing since 15 Oct 2018. CIK 0001700969

Company
Date
Role
Action
Shares
Amount
Of holding
12 Aug 2022
Director
Sold, plan not stated
10,000
$172.50K
4.4%
11 Aug 2022
Director
Sold, plan not stated
20,000
$330.00K
8.2%
22 Jun 2022
Director
Sold, plan not stated
10,000
$117.60K
4.1%
9 Sep 2021
Director
Sold, plan not stated
5,000
$127.70K
2.2%
20 Aug 2021
Director
Sold, plan not stated
10,000
$234.70K
4.2%
9 Jun 2021
Director
Sold, plan not stated
9,969
$249.72K
4.1%
15 Oct 2018
Director
Bought
15,000
$270.00K
8.2%
7 decisions on file.